References
1. The NHS Long Term Plan. NHS England. 2019. Available online at https://www.longtermplan.nhs.uk (accessed on 1.03.22).
2. A Fairer Healthier Scotland. NHS Scotland. 2017. Available online at http://www.healthscotland.scot/publications/a-fairer-healthier-scotland (accessed 27.03.22)
3. A Healthier Wales. Our Plan for Health and Social Care. NHS Wales. 2019. Available online at https://gov.wales/healthier-wales-long-term-plan-health-and-social-care (accessed 27.03.22)
4. Department of Health and Social Care. Genome UK: The future of healthcare. (2020) https://www.gov.uk/government/publications/genome-uk-the-future-of-healthcare (last accessed 12-4-22)
5. Department of Health and Social Care. Genome UK: Shared commitment for UK implementation (2022) https://www.gov.uk/government/publications/genome-uk-shared-commitments-for-uk-wideimplementation-2022-to-2025/genome-uk-shared-commitments-for-uk-wide-implementation-2022- to-2025 (last accessed 12-4-22)
6. International Consortium Completes Human Genome Project - All Goals Achieved; New Vision for Genome Research Unveiled. National Human Genome Research Institute. 2003. Available online at https://www.genome.gov/11006929/2003-release-international-consortium-completes-hgp (accessed on 8 March 2022).
7. The 100,000 Genomes Project. Genomic England. Available online at https://www.genomicsengland.co.uk/about-genomics-england/the-100000-genomes-project (accessed on 11 February 2022).
8. Owusu-Obeng A, Weitzel K.W, Hatton R.C., et al. Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy. 2014;34(10):1102-1112. DOI:10.1002/phar.1481.
9. Aneesh TP, Sonal S.M., Asha J. et al. Pharmacogenomics: The right drug to the right person. J Clin Med Res. 2009; 1(4): 191–194. DOI:10.4021/jocmr2009.08.1255
10. Haga S.B, LaPointe S.M, Cho A., et al. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting. Pharmacogenomics. 2014;15(13):1677-86. DOI:10.2217/pgs.14.109.
11. Youssef E, Kirkdale C.L., Wright D.J., et al. Estimating the potential impact of implementing preemptive pharmacogenetic testing in primary care across the UK. British Journal Clinical Pharmacology. 2020;87: 2907-2925. DOI: https://doi.org/10.1111/bcp.14704
12. Dervieux T, Brennan F, Scott R., et. al. Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications. Mutation Research. 2005;573: 180–194. DOI: 10.1016/j.mrfmmm.2004.07.025.
13. Maciel A, Cullors A, Lukowiaket A.A., et al. Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings. Neuropsychiatr Dis Treat. 2018; 14: 225–230. DOI:10.2147/NDT.S145046.
14. BPS/RCP. Personalised Prescribing: Using pharmacogenomics to improve patient outcomes. 2022. /https://www.bps.ac.uk/getmedia/b43a3dca-1bbf-4bff-9379-20bef9349a8c/Personalisedprescribing-full-report.pdf.aspx. (last accessed 09-5-22)
15. Breaux, S., Desrosiers, F. A. D., Neira, M., et al. Pharmacogenomics at the point of care: a community pharmacy project in British Columbia. Journal of Personalized Medicine. 2021; 11(1):11. DOI: 10.3390/jpm11010011
16. Wright D. Targeted medicines: how pharmacists can lead a pharmacogenomics revolution. Clinical Pharmacist. 2018;10(6). DOI:10.1211/CP.2018.20204938.
17. Streetman DS. Emergence and evolution of pharmacogenetics and pharmacogenomics in clinical pharmacy over the past 40 years. Annals of Pharmacotherapy. 2007;41(12):2038–2041. DOI:10.1345/aph.1K273.
18. Robinson J. Q&A: Why pharmacists must prepare for precision medicine. The Pharmaceutical Journal. 2017;299(7904). DOI: 10.1211/PJ.2017.20203118.
19. Wang, Y. T., Merl, M. Y., Yang, J., et al. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice. The Pharmacogenomics Journal. 2020;
20. (2): 169-178. DOI: 10.1038/s41397-019-0119-8 20. Elewa, H., Awaisu, A. Pharmacogenomics in pharmacy practice: current perspectives. Integrated Pharmacy Research & Practice. 2019; 8: 97. DOI: 10.2147/IPRP.S180154
21. Bright D.R., et. al. Implementation of a pharmacogenetic management service for post myocardial infarction care in a community pharmacy. Per Med. 2015;12(4):319-325. DOI: 10.2217/pme.15.7
22. Arwood, M. J., et al. Design and early implementation successes and challenges of a pharmacogenetics consult clinic. Journal of Clinical Medicine. 2020;9(7): 2274. DOI: 10.3390/jcm9072274
23. Bank, P. C., et al. A pilot study of the implementation of pharmacogenomic pharmacist initiated preemptive testing in primary care. European Journal of Human Genetics. 2019; 27(10): 1532-1541. DOI: 10.1038/s41431-019-0454-x
24. Bättig, V. A., et al. Pharmacogenetic testing in depressed patients and interdisciplinary exchange between a pharmacist and psychiatrists results in reduced hospitalization times. Pharmacopsychiatry. 2020;53(04): 185-192. DOI: 10.1055/a-1096-1171
25. Cicali, E. J., Weitzel, K. W., Elsey, A. R., et al. (2019). Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene–drug pairs across ambulatory care settings. Genet Med. 2019;21(10): 2264-2274. DOI: 10.1038/s41436-019-0500-7
26. Haga, S. B., Mills, R., Moaddeb, J., et al. Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing. Pharmacogenomics and Personalized Medicine. 2021;14: 877– 886. DOI: 10.2147/PGPM.S314972
27. Liko, I., Corbin, L., Tobin, E., et al. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program. American Journal of Health-System Pharmacy. 2021;78(12): 1094-1103. DOI: 10.1093/ajhp/zxab137
28. Luczak, T. S., Schillo, P. J., Renier, C. M., et al. Feasibility of pre-emptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting. Journal of Oncology Pharmacy Practice. 2022; 28(4):842-849. DOI: 10.1177/10781552211005529
29. Papastergiou, J., Quilty, L. C., Li, W., Thiruchselvam, T., et al. Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial. Clinical and Translational Science. 2021;14(4): 1359-1368. DOI: 10.1111/cts.12986
30. Patel, J. N., Boselli, D., Hamadeh, I. S., et al. Pain management using clinical pharmacy assessments with and without pharmacogenomics in an oncology palliative medicine clinic. Journal of Oncology Practice, 2020; 16(2): e166-e174. DOI: 10.1200/JOP.19.00206
31. Thornley, T., Esquivel, B., Wright, D. J., et al. Implementation of a Pharmacogenomic Testing Service through Community Pharmacy in the Netherlands: Results from an early service evaluation. Pharmacy (Basel). 2021; 9(1): 38. DOI: 10.3390/pharmacy9010038
32. Van der Wouden, C. H., Bank, P. C., Özokcu, K., et al. Pharmacist-initiated pre-emptive pharmacogenetic panel testing with clinical decision support in primary care: record of PGx results and real-world impact. Genes (Basel). 2019; 10(6): 416. DOI: 10.3390/genes10060416
33. Crews K.R., et al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. American Journal of Health-System Pharmacy. 2011;68(2):143-50. DOI:10.2146/ajhp100113.
34. Mills R, Haga SB. The Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. Pharmacogenomics. 2013;14(8):957-68. DOI:10.2217/pgs.13.76.
35. Haga SB, et al. Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing. Pharmacogenomics. 2017;18(4):359-367. DOI:10.2217/pgs-2016-0177.
36. Johnson SG, et al. Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system. Pharmacy Practice (Granada). 2017;15(2):946. DOI:10.18549/PharmPract.2017.02.946.
37. Papastergiou J, et. al. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study. Journal of the American Pharmacists Association. 2017;57(5):624-629. DOI: 10.1016/j.japh.2017.05.006.
38. Bain K.T, et al. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE). Journal of the American Pharmacists Association. 2018;58(3):281-289.e1. DOI:10.1016/j.japh.2018.02.011.
39. Rodríguez-Arcas MJ, et. al. Pharmacotherapeutic follow-up and pharmacogenetics of CYP2C9 and CYP3A4 in antihypertensive therapy: A pilot study in a community pharmacy. Ther Innov Regul Sci. 2013;47(4):489-494. DOI: 10.1177/2168479013492736
40. Elhassan GO, et al. Role of pharmacists in pharmacogenomics. Journal of Pharmacovigilance. 2017;5:3. DOI:10.4172/2329-6887.1000e170.
41. Hicks, J. K., Aquilante, C. L., Dunnenberger, H. M., et al. Precision pharmacotherapy: integrating pharmacogenomics into clinical pharmacy practice. Journal of the American College of Clinical Pharmacy. 2019;2(3):303-313. DOI: 10.1002/jac5.1118
42. Guy, J. W., Patel, I., & Oestreich, J. H. Clinical application and educational training for pharmacogenomics. Pharmacy. 2020;8(3):163. DOI: 10.3390/pharmacy8030163
43. Hayashi, M., Hamdy, D. A., & Mahmoud, S. H. Applications for pharmacogenomics in pharmacy practice: A scoping review. Research in Social and Administrative Pharmacy. 2021. S1551- 7411(21)00313-2. DOI: 10.1016/j.sapharm.2021.08.009
44. Hansen, J. M., Nørgaard, J. D., & Sporrong, S. K. A systematic review of pharmacogenetic testing in primary care: Attitudes of patients, general practitioners, and pharmacists. Research in Social and Administrative Pharmacy. 2021. S1551-7411(21)00387-9. DOI: 10.1016/j.sapharm.2021.12.002.
45. Turner R, Newman W, Bramon E et al. Pharmacogenomics in the UK National Health Service: Opportunities and challenges. Pharmacogenomics. 2020; 21(17):1237-1246. DOI: 10.2217/pgs- 2020-0091.Instrumental]